International Journal of Cardiovascular Imaging

We are passionate about teaching cardiovascular imaging to the medical community!

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Groundbreaking work that Elazer Edelman is doing in endothelium and biomaterials using imaging as endpoint
If you want to know more about CV imaging, follow us and read our articles! @IntJCVImaging
#echofirst
#yescct
#whyCMR

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

One of the best lectures I have ever attended! Only Elazar Edelman can mix together endothelium, quantum physics, history, philosophy, determinism vs heuristics, through the lens of modernism
Love the reenactment of the famous image of Laennec auscultation! (2nd photo) @DLBHATTMD

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

One of the best lectures I have ever attended! Only Elazar Edelman can mix together endothelium, quantum physics, history, philosophy, determinism vs heuristics, through the lens of modernism
Love the reenactment of the famous image of Laennec auscultation! (2nd photo) @DLBHATTMD

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

It is my honor and my privilege to be a Discussant for the Late-Breaking Clinical Trial Session editorializing the SOUL trial
Oral semaglutide ⬇️3P-MACE by 14% in T2DM with CVD and/or CKD. Plus improvement in PAD events too
@DLBHATTMD @dranulala @MountSinaiHeart @IcahnMountSinai

[International Journal of Cardiovascular Imaging @IntJCVImaging]

What a great moment to be working in HFpEF specifically and cardiometabolism in general!

Wanna learn how to evaluate HFpEF using imaging? Read our journal @IntJCVImaging

#echofirst #yesCCT
#whyCMR

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Another summit (see what I did here?) in the HFpEF revolution! The dual GLP1/GIP mimetic tirzepatide improves outcomes in HFpEF with obesity!

SUMMIT trial showed 38% ⬇️ in HF outcomes (=time-to-first HFH, oral diuretic intensification and CV death)!! https://t.co/apLuJ4n2X4

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Non-invasive methods to replace cardiac biopsy in heart transplant surveillance. Way to go, @JeffTeuteberg @Stanford_HF!👏

If you focus on non-invasive evaluation of the heart, read @IntJCVImaging!
@purviparwani @CASivaram1 @argulian @LucySafi
@DrRyanPDaly @onco_cardiology

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

So thrilled to have the extraordinary and amazingly talented clinician @JeffTeuteberg as our Visiting Professorship at @MountSinaiHeart
Leading the change for biomarkers to replace cardiac biopsy in cardiac transplant surveillance
@DLBHATTMD @dranulala @spinneymd @DonnaMancini11

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Cardiometabolism evaluation via imaging techniques = @PamTaubMD
Cardiometabolism improvement via time-restricted eating=@PamTaubMD

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

What a tour de force by the amazing @PamTaubMD as Visiting Professor at @MountSinaiHear!
She masterfully took us through her journey from cardiometabolism to time-restricted eating to POTS to Long Covid, all with impeccable scientific accumen and humility!
@DLBHATTMD

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Do not miss this session!

@SantosGallegoMD uses imaging to evaluate the effect of therapies, both for HFrEF and for HFpEF

If you want to learn more about imaging, ready our journal @IntJCVImaging

#cardioed #meded #echofirst #yesCCT #whyCMR

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Very proud to be invited to lecture at #AHA2023 about dual SGLT1/2 inhibition as a novel strategy for HFpEF!

Saturday 11/11 at 3.15-4.30pm to learn HFpEF therapies from amazing experts @mvaduganathan @andrewjsauer @FudimMarat @HFpEF @KMAlexanderMD @JenHoCardiology @RBPatelMD

[International Journal of Cardiovascular Imaging @IntJCVImaging]

That is a hefty cut!!
Efficacy of SGLT2i on HF demonstrated both clinically and using imaging.
For imaging studies in HF, please read @IntJCVImaging #echofirst #whyCMR #yesCCT #cardioed #meded

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Wow! An SGLT2i is sold at $47.85!!!! (shipping included) 🥳🍾🎉🤑💸
That is 8% of the going price of empagliflozin or dapagliflozin!!
Caveat: Only indication in T2DM (not HF or CKD)
https://t.co/e17wlZfHM5
@ChristosArgyrop @JonathanDavisHF @AndrewJSauer @hvanspall @dranulala

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Proud to present tomorrow the latest evidence at #ADA2023 about SGLT2i and heart failure.
Best panel ever with my friends Darren McGuire (discussing SGLT2i/GLP1RA) and @PamTaubMD (discussing GLP-1RA in CVD), moderated by @gandaom
@DLBHATTMD @GoggleDocs
https://t.co/kOM7zQKQNC

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Amazing talk about GLP-1RA by the incredibly talented @PamTaubMD!
Loved that she focused on novel fields beyond the "traditional" weight loss effects
#ADA2023

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Breaking news: FDA has just approved sotagliflozin (brand name "Inpefa") for Treatment of Heart Failure!!!!

Broad label across full LVEF range (HFpEF&HFrEF), and for patients with or without T2DM

First dual SGLT1/2 inhibitor to be approved in HF

@DLBHATTMD @ChristosArgyrop

[International Journal of Cardiovascular Imaging @IntJCVImaging]

RV evaluation is very tricky. If you want to it properly

1) learn from the master himself @RyanTedfordMD

2) read our journal @IntJCVImaging

#echofirst #whyCMR #yesCCT
#cardioed @NephroP

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

I have learnt so many concepts about RV evaluation from thr master himself, the one and only @RyanTedfordMD, in the Grand Rounds at #McMaster organized by @hvanspall
Importance of RV/PA coupling over contractility, of exercise/pharmacological reserve over at-rest evaluation,…

[Paul Schoenhagen @PSchoenhagen]

Identification of acute aortic syndromes based on cross-sectional vari... https://t.co/iKxxeZo7dq

[International Journal of Cardiovascular Imaging @IntJCVImaging]

AddThis | Home https://t.co/yLrB3c8iVt

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Great use of cardiovascular imaging techniques to demonstrate that empagliflozin reduces MI size!

If you want to learn more about cardiac imaging, read our journal @IntJCVImaging

[Juanbadimon @juanbadimon]

Should we consider increased ketone body levels as one of the mechanisms of action involved in the cardiorenal benefit of SGLT2i?

Our recent article supports this concept! @santosgallegoMD @RequenaIbanez

@dlbhattmd @IcahnMountSinai @SinaiCards

https://t.co/l9QnaAvKib

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

Happy birthday to an amazing scientist, cardiologist and person! @Hinaheartdoc

@bingyanw @sanginair @RequenaIbanez @juanbadimon @DLBHATTMD @DrDavidReich @rahatheart1 @AnastasiaSMihai @aayshacader @ErinMichos

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Great editorial comment about the CLEAR Outcomes trial by the world-renown lipid expert @juanbadimon

As we are an imaging journal, this trial could only be better if it also had imaging endpoints!

#whyCMR #yesCCT #echofirst

[Juanbadimon @juanbadimon]

Everything you wanted to know about the CLEAR-Outcomes trial, but were afraid to ask.

Read my view on the latest @secardiologia blog entry

LDL, the lower the better, the earlier the better!

https://t.co/dteyF3BRRI

@lipidmir @ResiSec #cardioed #meded @Capijorge1

[International Journal of Cardiovascular Imaging @IntJCVImaging]

Great review by @SantosGallegoMD about techniques to quantify congestion, including VExUS!
#cardioed #meded #echofirst #yesCCT #whyCMR

[Soc Esp Cardiología @secardiologia]

"EMPULSE: en insuficiencia cardiaca aguda, empagliflozina causa mejoría de la congestión temprana, efectiva y sostenida en el tiempo, que se asocia con beneficio clínico a largo plazo", señala @santosgallegoMD. #BlogSEC @jovenesSEC https://t.co/BjnW6mEiNY

[International Journal of Cardiovascular Imaging @IntJCVImaging]

That is why we chose @SantosGallegoMD as Associate Editor of our journal @IntJCVImaging

[Alexander Hajduczok, MD 🇺🇦🙏 @AHajduczok]

With every passing day I learn that @SantosGallegoMD is an expert on another topic (SGLT2i, Spanish wine, opera, Futbol, tapas, bourbon…the list is endless). @rachkataria and @JonathanDavisHF decided that he is the most interesting man in the world. (#AHA22 edition)

[International Journal of Cardiovascular Imaging @IntJCVImaging]

@AHajduczok @SantosGallegoMD @rachkataria @JonathanDavisHF @JJheart_doc @hvanspall @AndrewJSauer @QuentinYoumans @MGsHusband @Jcontreras75 @RyanTedfordMD @docbhardwaj @DrMarthaGulati @PPirlamarla_MD That is why we chose him as Associate Editor of our journal @IntJCVImaging